RMTI - Rockwell Medical Technologies Inc.

RMTI Stock Chart

RMTI Profile

Rockwell Medical, Inc., headquartered in Wixom, Michigan, operates as a biopharmaceutical company focused on addressing end-stage renal disease (ESRD) and chronic kidney disease (CKD) through specialized therapies and products, both domestically and internationally. The company's primary offerings include Triferic Dialysate and Triferic AVNU, innovative iron therapies designed to effectively manage iron deficiency and maintain hemoglobin levels in dialysis patients, all while minimizing iron stores. These products play a crucial role in enhancing patient outcomes without compromising safety.

In addition to its flagship iron therapies, Rockwell Medical manufactures and distributes a comprehensive range of hemodialysis concentrates essential for dialysis treatment. These include CitraPure citric acid concentrate, Dri-Sate dry acid concentrate, RenalPure liquid acid concentrate, and various bicarbonate concentrates like RenalPure and SteriLyte powder. These products are vital for maintaining proper electrolyte balance and removing toxins from the bloodstream during hemodialysis, thus supporting critical life-sustaining processes.

The company also supplies a variety of ancillary products indispensable to hemodialysis providers, such as blood tubing, fistula needles, dialyzers, specialized component kits, and essential medical supplies. Beyond its core dialysis focus, Rockwell Medical is actively developing therapeutic candidates aimed at addressing acute heart failure in hospitalized patients, as well as advancing home infusion therapies that enable patients to receive intravenous medications in the comfort of their homes.

Rockwell Medical serves a diverse customer base that includes medium-sized and small dialysis chains, as well as independent dialysis centers. Established in 1996, the company continues to expand its global footprint while remaining steadfast in its commitment to advancing therapies that improve the quality of life for patients suffering from kidney-related illnesses.

RMTI Revenue Chart

RMTI Earnings

Analyst Ratings